406 completed, 83 unknown, 29 recruiting, 24 terminated. 233 Not applicable, 98 Phase 4, 84 Phase 3, 54 Phase 2, 23 Phase 1.
Follow Attention Deficit Hyperactivity Disorder: new trials by email Literature Review of Attention Deficit Hyperactivity Disorder trials Research Report on Attention Deficit Hyperactivity Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CBT for Adult Inmates With ADHD PROBECO, Formulation-based cognitive behavioral therapy - Attention Deficit Hyperactivity Disorder | Not applicable | Not yet recruiting | Universidad Europea de Valencia | 111 | 2027-09-01 | 2026-05-06 |
| Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy Psychotherapy - Irritability, Disruptive Mood Dysregulation Disorder | Recruiting | National Institute of Mental Health (NIMH) | 410 | 2026-10-27 | 2026-10-22 | |
| Evaluation of Foquest in Adults 65 Years and Older With ADHD Methylphenidate hydrochloride extended-release capsules - Attention Deficit Hyperactivity Disorder | Phase 4 | Recruiting | Dar Clinical Research Inc. | 36 | 2026-10-06 | 2026-10-07 |
| Adult ADHD Symptoms, Depression, Anxiety, and Academic Performance in Medical Students Attention Deficit Hyperactivity Disorder, Depression | Not yet recruiting | Assiut University | 52 | 2026-10-01 | 2026-09-03 | |
| Cardiovascular Safety of Atomoxetine in Children With ADHD Attention Deficit Hyperactivity Disorder | Not yet recruiting | Assiut University | 82 | 2026-09-30 | 2026-10-05 | |
| Multi-Component Training Versus Motor Learning Techniques in Adults With ADHD Multi-Component Training, Motor Learning Techniques - Attention Deficit Hyperactivity Disorder | Not applicable | Not yet recruiting | Riphah International University | 44 | 2026-09-10 | 2026-09-29 |
| A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD AK-D101, Placebo - Attention Deficit Hyperactivity Disorder, Attention-Deficit / Hyperactivity Disorder | Phase 3 | Not yet recruiting | Alvogen Korea | 156 | 2026-07-01 | 2026-07-02 |
| Photography-Based Intervention for Children With Attention Deficit Hyperactivity Disorder Photography-based psychoedication - Attention Deficit Hyperactivity Disorder | Not applicable | Active not recruiting | The Hong Kong Polytechnic University | 60 | 2026-06-15 | 2026-09-08 |
| The Effect of Playful Physiotherapy Intervention Playful physiotherapy programme - Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder | Not applicable | Recruiting | University of Tartu | 25 | 2026-05-01 | 2026-05-05 |
| Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery Test, Questionnaires - Neurodevelopmental Disorders, Autism Spectrum Disorder | Not applicable | Recruiting | Assistance Publique - Hôpitaux de Paris | 100 | 2026-04-08 | 2026-04-16 |
| Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children Inulin, Probiotic, Omega-3 Fatty Acids - Attention Deficit Hyperactivity Disorder | Not applicable | Recruiting | Khyber Medical University Peshawar | 68 | 2026-03-01 | 2026-06-24 |
| Improving Self-regulation in Individuals With ADHD Through Adapted Karate Training Adapted karate training - Attention Deficit Hyperactivity Disorder | Not applicable | Not yet recruiting | Tel Aviv University | 55 | 2026-02-26 | 2026-02-24 |
| R61/33 - VR Study Phase 4 Meta Quest 3 VR Headset with noise cancelling headphones - Attention Deficit Hyperactivity Disorder | Phase 4 | Recruiting | Rutgers, The State University of New Jersey | 252 | 2025-09-09 | 2026-01-28 |
| Effects of Transcranial Photobiomodulation in ADHD Active transcranial photobiomodulation, Sham transcranial photobiomodulation - Attention Deficit Hyperactivity Disorder | Not applicable | Recruiting | Francisco Gonzalez-Lima, PhD | 140 | 2025-09-01 | 2026-06-22 |
| A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder BI 3031185, Placebo - Borderline Personality Disorder, Attention Deficit Hyperactivity Disorder | Phase 1 | Completed | Boehringer Ingelheim | 78 | 2025-08-12 | 2026-08-10 |
| Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure Trigeminal Nerve Stimulation (TNS) - Fetal Alcohol Spectrum Disorders, Attention Deficit Hyperactivity Disorder | Not applicable | Recruiting | University of California, Los Angeles | 30 | 2025-04-26 | 2026-07-16 |
| Mobile Behavioral Parent Training for Childhood ADHD: Pilot Trial Mobile Behavioral Parent Training (mBPT), Just-in-time intervention: Parenting Strategies - Attention Deficit Hyperactivity Disorder | Not applicable | Completed | Florida International University | 56 | 2024-11-01 | 2025-08-29 |
| Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD Power Down manipulation - Attention Deficit Hyperactivity Disorder, Sleep Disturbance | Not applicable | Completed | University of Pittsburgh | 30 | 2024-11-01 | 2026-08-14 |
| Virtual Reality Treatment for Emerging Adults With ADHD Meta Quest 3 VR Headset with noise cancelling headphones - Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | Rutgers, The State University of New Jersey | 60 | 2024-09-20 | 2026-01-02 |
| Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD HLD200 methylphenidate hydrochloride capsules, Placebo HLD200 capsules - Attention Deficit Hyperactivity Disorder | Phase 3 | Terminated | Ironshore Pharmaceuticals and Development, Inc | 26 | 2024-09-13 | 2025-11-06 |
Showing 20 of 573. Sign in to see all of them.
Attention Deficit Disorder with Hyperactivity (573) · Autism Spectrum Disorder (38) · Oppositional Defiant Disorder (18) · Neurodevelopmental Disorders (17) · Anxiety Disorders (14) · Substance-Related Disorders (12) · Conduct Disorder (11) · Impulsive Behavior (11) · Spasm (11) · Depression (10) · Attention Deficit and Disruptive Behavior Disorders (9) · Intellectual Disability (9) · Mental Disorders (9) · Autistic Disorder (7) · Bipolar Disorder (7)
Attention Deficit and Disruptive Behavior Disorders (564) · Mental Disorders (564) · Neurodevelopmental Disorders (556) · Nervous System Diseases (55) · Behavior (48) · Pathological Conditions, Signs and Symptoms (47) · Signs and Symptoms (44) · Child Development Disorders, Pervasive (39) · Neurologic Manifestations (39) · Neurobehavioral Manifestations (24) · Behavioral Symptoms (18) · Chemically-Induced Disorders (17) · Communication Disorders (15) · Sleep Wake Disorders (13) · Neuromuscular Manifestations (11)
Methylphenidate (84) · Atomoxetine Hydrochloride (65) · Lisdexamfetamine Dimesylate (21) · Therapeutics (15) · Amphetamine (9) · Cognitive Behavioral Therapy (8) · Guanfacine (7) · Sugars (7) · 5,10-dihydro-5-methylphenazine (6) · Dexmethylphenidate Hydrochloride (6) · Dextroamphetamine (6) · Transcranial Direct Current Stimulation (6) · Melatonin (5) · SLI381 (5) · 1-(naphthalen-2-yl)-3-azabicyclo(3.1.0)hexane (4)
Eli Lilly and Company (42) · Massachusetts General Hospital (23) · Children's Hospital Medical Center, Cincinnati (18) · National Taiwan University Hospital (15) · National Institute of Mental Health (NIMH) (10) · Chinese University of Hong Kong (8) · Florida International University (7) · NYU Langone Health (7) · Hospital de Clinicas de Porto Alegre (6) · Karolinska Institutet (6) · Otsuka Pharmaceutical Development & Commercialization, Inc. (6) · Pfizer (6) · Akili Interactive Labs, Inc. (5) · Assiut University (5) · Duke University (5)
United States (267) · Canada (33) · Taiwan (28) · Israel (24) · Germany (20) · Netherlands (18) · Sweden (18) · United Kingdom (17) · France (16) · Brazil (13) · China (13) · South Korea (13) · Spain (11) · Italy (10) · Norway (10)
Susan Shur-Fen Gau, MD, PhD (9) · Thomas Spencer, MD (5) · Timothy Wilens, MD (5) · Ann Childress, MD (4) · Jeffrey Newcorn, MD (4) · Craig Surman, MD (3) · Joan Camprodon, MD, PhD, MPH (3) · Joseph Biederman, MD (3)
PMID 25019647, PMID 37058600, PMID 36971690, PMID 38685016, PMID 41342306, PMID 10385840, PMID 21367347, PMID 21432592, PMID 21569378, PMID 23137723, PMID 23356790, PMID 24636025, PMID 25266438, PMID 25877989, PMID 27082828, PMID 38824626, PMID 39128918, PMID 40527386, PMID 10560028, PMID 10990547, PMID 11389303, PMID 11409829, PMID 11514638, PMID 11581440, PMID 11864719, PMID 12139997, PMID 12578439, PMID 13539317, PMID 14199369, PMID 14527115, PMID 14595084, PMID 14675812, PMID 15076258, PMID 15076267, PMID 15257968, PMID 1537959, PMID 15381021, PMID 15656741, PMID 15685125, PMID 15724142, PMID 15753425, PMID 15869352, PMID 15910203, PMID 15934489, PMID 15950006, PMID 15950016, PMID 15969353, PMID 16041867, PMID 16175106, PMID 16262992
2014 (2), 2015 (2), R61MH113663 (2), R61MH131632 (2), 2009 (1), 2018 (1), 2019 (1), 2023 (1), K01NR017465 (1), K23MH108704 (1), K24AA000301 (1), K24DA016264 (1), P30MH071478 (1), P50HD093074 (1), R00MH102349 (1)